TAKEDA PHARMA (TKD.SG)
TAKEDA PHARMA (TKD.SG) operates in Diversified Metals & Mining.
TAKEDA PHARMA (TKD.SG) (TKD) - Total Assets
Latest total assets as of September 2024: €14.57 Trillion EUR
Based on the latest financial reports, TAKEDA PHARMA (TKD.SG) (TKD) holds total assets worth €14.57 Trillion EUR as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
TAKEDA PHARMA (TKD.SG) - Total Assets Trend (2014–2024)
This chart illustrates how TAKEDA PHARMA (TKD.SG)’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
TAKEDA PHARMA (TKD.SG) - Asset Composition Analysis
Current Asset Composition (March 2024)
TAKEDA PHARMA (TKD.SG)'s total assets of €14.57 Trillion consist of 16.9% current assets and 83.1% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 3.0% |
| Accounts Receivable | €718.67 Billion | 4.8% |
| Inventory | €1.21 Trillion | 8.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €4.27 Trillion | 28.3% |
| Goodwill | €5.41 Trillion | 35.8% |
Asset Composition Trend (2014–2024)
This chart illustrates how TAKEDA PHARMA (TKD.SG)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: TAKEDA PHARMA (TKD.SG)'s current assets represent 16.9% of total assets in 2024, a decrease from 34.9% in 2014.
- Cash Position: Cash and equivalents constituted 3.0% of total assets in 2024, down from 14.6% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 63.0% of total assets, an increase from 41.0% in 2014.
- Asset Diversification: The largest asset category is goodwill at 35.8% of total assets.
TAKEDA PHARMA (TKD.SG) Competitors by Total Assets
Key competitors of TAKEDA PHARMA (TKD.SG) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MANHATTAN ASSOC
BE:MHT
|
Germany | €698.14 Million |
|
TV BROADCAST
MU:TBCN
|
Germany | €6.25 Billion |
|
FIRST CITIZENS BC A
BE:FC6A
|
Germany | €220.57 Billion |
|
COSTCO WHSL
MU:CTO
|
Germany | €69.83 Billion |
|
GOLDMAN SACHS GROUP - Dusseldorf Stock Exchang
DU:GOS
|
Germany | €1.73 Trillion |
|
BURCKHARDT COMPRE N
MU:B5H
|
Germany | €1.07 Billion |
|
Public Service Company of New Mexico PFD 4.58%
PINK:PNMXO
|
USA | $886.19 Million |
|
2H0
F:2H0
|
Germany | €15.27 Million |
TAKEDA PHARMA (TKD.SG) - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - TAKEDA PHARMA (TKD.SG) generates 0.28x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, TAKEDA PHARMA (TKD.SG) generates $ 0.95 in net profit.
TAKEDA PHARMA (TKD.SG) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.28 | 1.04 | 1.18 |
| Quick Ratio | 0.77 | 0.55 | 0.81 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €666.78 Billion | € 94.45 Billion | € 392.96 Billion |
TAKEDA PHARMA (TKD.SG) - Advanced Valuation Insights
This section examines the relationship between TAKEDA PHARMA (TKD.SG)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 8.2% |
| Total Assets | €15.11 Trillion |
| Market Capitalization | $284.05K USD |
Valuation Analysis
Below Book Valuation: The market values TAKEDA PHARMA (TKD.SG)'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: TAKEDA PHARMA (TKD.SG)'s assets grew by 8.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for TAKEDA PHARMA (TKD.SG) (2014–2024)
The table below shows the annual total assets of TAKEDA PHARMA (TKD.SG) from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-03-31 | €15.11 Trillion | +8.25% |
| 2023-03-31 | €13.96 Trillion | +5.92% |
| 2022-03-31 | €13.18 Trillion | +2.06% |
| 2021-03-31 | €12.91 Trillion | +0.71% |
| 2020-03-31 | €12.82 Trillion | -7.58% |
| 2019-03-31 | €13.87 Trillion | +237.82% |
| 2018-03-31 | €4.11 Trillion | -5.72% |
| 2017-03-31 | €4.36 Trillion | +13.90% |
| 2016-03-31 | €3.82 Trillion | -10.99% |
| 2015-03-31 | €4.30 Trillion | -5.97% |
| 2014-03-31 | €4.57 Trillion | -- |